Boiron SA (EPA:BOI)

Market Cap	526.08M
Revenue (ttm)	504.86M
Net Income (ttm)	19.37M
Shares Out	17.36M
EPS (ttm)	1.12
PE Ratio	27.16
Forward PE	19.40
Dividend	1.20 (3.96%)
Ex-Dividend Date	Jun 3, 2025

Volume	235
Average Volume	1,402
Open	30.35
Previous Close	30.30
Day's Range	29.75 - 30.35
52-Week Range	20.85 - 32.25
Beta	0.35
RSI	61.03
Earnings Date	Mar 20, 2026

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for ad...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,771
• Stock Exchange: Euronext Paris
• Ticker Symbol: BOI

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.